required
for other indications, in individuals with a recent primary intracerebral
haemorrhage.’
click here showed an increase in haemorrhagic stroke risk with statins.
However, other RCTs have not shown an increased risk and
the recent primary prevention Cochrane meta-analysis
did not show an increased risk. The most reassuring data however comes from a
meta-analysis of all RCTs which have reported stroke as an outcome Stroke
meta-analysis 2012 In
this study of 95,000 patients statin therapy was not associated with
significant increase in ICH. A significant reduction in all stroke and
all-cause mortality was observed with statin therapy.
There has been a question mark that statins may increase intracerebral
haemorrhage, so in patients who have had a recent haemorrhagic stroke the RCP
guidance seems prudent and sensible. However, more recent data is reassuring
and given that the benefits of statins are so clear in established vascular
disease then in patients with co-morbidity (e.g. previous haemorrhagic stroke
and established ischaemic heart disease) individualised decisions will need to
be made between you, your patient and the specialist. The most important thing, of course, for both types of stroke is good BP control <130/80.
Heart disease is multifactorial and inflammation does not exclude other factors. Poor cholesterol ratios (TC/HDL) is still a risk factor. Treatment did not disproportionately affect the hemorrhagic stroke risk associated with these other factors. There were no relationships between hemorrhage risk and baseline LDL-C levels or recent LDL-C levels in treated patients.
ReplyDeleteThanks
generic lisinopril